Monitor closing conditions and integration progress. The deal is small and the Target Group's unaudited financials may adjust.
Price Chart
Executive Summary
Cuprina Holdings acquires 100% of East Coast Podiatry (5 clinics) and Orchard Clinic (2 clinics) for ~S$4.0M (~US$3.1M), with 75% cash and 25% stock. The Target Group generated FY2025 unaudited revenue of S$9.1M and normalized EBITDA of S$1.2M.
Key Financial Metrics
Key Facts
- Acquires 100% of East Coast Podiatry Centre (5 clinics) and Orchard Clinic Management (2 clinics) for ~S$4.0M (~US$3.1M)
- Consideration: S$3.0M cash (75%) + S$1.0M in Class A ordinary shares (25%) with lock-up
- Target Group FY2025 unaudited revenue: S$9.1M (~US$7.0M); unaudited normalized EBITDA: S$1.2M (~US$0.9M)
- Closing expected on or before November 1, 2026, subject to customary conditions
Financial Impact
Acquisition consideration of ~US$3.1M; Target Group revenue of ~US$7.0M and EBITDA of ~US$0.9M (unaudited). Deal value is small relative to Cuprina's market cap (not stated in filing).
Risk Factors
- Target Group financials are unaudited and may be adjusted upon audit
- Consideration shares create dilution for existing shareholders
- Integration risk: Cuprina is a biomedical company acquiring clinical service businesses
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3373830 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 6-K | $1.93 | awaiting T+5 | — | $1.78 (+7.77%) |
Oct 2, 2026 24d ago | 6-K | $2.42 $1.69 | ▼ −30.17% | ▼ −31.33% | $1.78 (−26.45%) |
Oct 2, 2026 24d ago | Press Release | $2.42 $1.69 | ▼ −30.17% | ▼ −31.33% | $1.78 (−26.45%) |
Sep 29, 2026 26d ago | 6-K | $2.28 $1.99 | ▲ +12.72% | ▲ +14.63% | $1.78 (+21.93%) |
Sep 29, 2026 26d ago | Press Release | $2.28 $1.99 | ▲ +12.72% | ▲ +14.63% | $1.78 (+21.93%) |
Sep 18, 2026 5w ago | 6-K | $1.79 $1.87 | ▼ −4.47% | ▼ −3.20% | $1.78 (+0.56%) |
Sep 17, 2026 5w ago | 6-K | $1.79 $1.87 | ▼ −4.47% | ▼ −3.20% | $1.78 (+0.56%) |
Sep 17, 2026 5w ago | Press Release | $1.79 $1.87 | ▼ −4.47% | ▼ −3.20% | $1.78 (+0.56%) |
Sep 16, 2026 5w ago | 424B4 | $1.60 $1.88 | ▼ −17.50% | ▼ −15.68% | $1.78 (−11.25%) |
Sep 16, 2026 5w ago | EFFECT | $1.60 $1.88 | ▼ −17.50% | ▼ −14.94% | $1.78 (−11.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers